Regencell Bioscience Holdings Ltd. (RGC) News
Filter RGC News Items
RGC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest RGC News From Around the Web
Below are the latest news stories about REGENCELL BIOSCIENCE HOLDINGS LTD that investors may wish to consider to help them evaluate RGC as an investment opportunity.
One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 0.5% in the previous yearLooking at Regencell Bioscience Holdings Limited's ( NASDAQ:RGC ) insider transactions over the last year, we can see... |
With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's futureKey Insights Insiders appear to have a vested interest in Regencell Bioscience Holdings' growth, as seen by their... |
Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although... |
RGC: Forging a New Approach to ADHD and ASDBy Brad Sorensen, CFA NASDAQ:RGC Traditional “western” medicine has made amazing advances and is one of the great innovations in history, but, unfortunately, there are still many conditions afflicting people that western medicine hasn’t been able to treat with any great effectiveness. It’s in instances like these that it can be beneficial to look to a medical approach that’s been around for over |
One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous yearInsiders were net buyers of Regencell Bioscience Holdings Limited's ( NASDAQ:RGC ) stock during the past year. That is... |
81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recentlyEvery investor in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) should be aware of the most powerful shareholder... |
Regencell Bioscience’s Standardized Formulae Are Shown to Reduce ADHD and ASD Symptoms in the Interim Results of its Second Efficacy TrialHONG KONG, September 12, 2022--Regencell Bioscience Holdings Limited (Nasdaq: RGC) ("Regencell") today announced its interim results from its second efficacy trial. |
RGC: CEO Figuratively Putting His Money Where His Mouth IsBy Beth Senko, CFA NASDAQ:RGC Investors have faced challenging and volatile markets so far in 2022 as they sort through issues of inflation, supply chain disruption, continued covid issues, rising interest rates, and the disruption of the war in Ukraine. The S&P 500 has come close to bear market levels, down 19% in mid-June. Times of turbulence affect all stocks, large and small. It can be |